Literature DB >> 6975780

Cell volumes of normal and malignant mononuclear cells.

E H Chapman, A S Kurec, F R Davey.   

Abstract

The cell volumes of mononuclear cells, T lymphocytes, B lymphocytes, and monocytes from the peripheral blood of 20 normal individuals were compared to neoplastic lymphoid cells from 14 patients with chronic lymphocytic leukaemia (CLL), 20 individuals with acute lymphocytic leukaemia (ALL), and 18 cases of non-Hodgkin's lymphoma (NHL). Normal T cells were obtained by rosetting mononuclear cells with sheep erythrocytes followed by centrifugation on a gradient composed of Ficoll and diatrizoate salts. Monocyte populations were prepared by adhering mononuclear cells to plastic dishes and B cells were obtained by the depletion of T lymphocytes and monocytes from a mononuclear cell population. Cell volumes were determined on a Coulter Counter Model H4 Channelyzer. In normals, the average mean cell volume (MCV) of T lymphocytes was smaller than B lymphocytes and the average MCV of B lymphocytes was smaller than the average MCV of monocytes (p less than 0.05). The average MCV of lymphocytes from patients with CLL was smaller than the average MCV of normal B cells (p less than 0.01). The average MCV of lymphoblasts from cases of ALL was larger than the average MCV of normal peripheral blood lymphocytes (p less than 0.01). In addition, the size of lymphoblasts showed great variation within and among cases of ALL. The MCV of lymphocytes from most cases of NHL was larger than the MCV of lymphocytes from reactive lymph nodes and from the peripheral blood of normal individuals. An association was observed between the MCV of neoplastic cells and the classification according to Rappaport. We believe that the measurement of lymphoid cell volumes may be helpful in the diagnosis and prognosis of patients with a variety of lymphoproliferative disorders.

Entities:  

Mesh:

Year:  1981        PMID: 6975780      PMCID: PMC494369          DOI: 10.1136/jcp.34.10.1083

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  32 in total

1.  Immunologic functions of isolated human lymphocyte subpopulations. V. Isolation and functional analysis of a surface Ig negative, E rosette negative subset.

Authors:  R P Mac Dermott; L Chess; S F Schlossman
Journal:  Clin Immunol Immunopathol       Date:  1975-09

2.  The average volume of leukemic leukocytes.

Authors:  H TIVEY; J G LI; E E OSGOOD; M DUERST; V KLOBUCHER; E PETERSON; M E HUGHES
Journal:  Blood       Date:  1951-11       Impact factor: 22.113

3.  Electrical sizing of particles in suspensions. IV. Lymphocytes.

Authors:  S Ben-Sasson; D Patinkin; N B Grover; F Doljanski
Journal:  J Cell Physiol       Date:  1974-10       Impact factor: 6.384

4.  Sedimentation and volume analysis of human bone marrow.

Authors:  R Moon; R A Phillips; R G Miller
Journal:  Ser Haematol       Date:  1972

5.  Immunoglobulins on the surface of human lymphocytes.

Authors:  M Papamichail; J C Brown; E J Holborow
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

6.  Classification and subclassification of acute leukemias correlated with clinical expression, therapeutic sensitivity and prognosis.

Authors:  G Mathé; P Pouillart; R Weiner; M Hayat; M Steresco; M Lafleur
Journal:  Recent Results Cancer Res       Date:  1973

7.  The volume distribution of human lymphocytes.

Authors:  D W Westring; J L Ladinsky; P Feick
Journal:  Proc Soc Exp Biol Med       Date:  1969-07

8.  Human leukocytes: their size distribution and mean corpuscular volume.

Authors:  J Gauthier; P Harel
Journal:  Can Med Assoc J       Date:  1967-09-23       Impact factor: 8.262

9.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

10.  Differential white cell counts by frequency distribution analysis of cell volumes.

Authors:  N C Hughes-Jones; I Norley; J M Young; J M England
Journal:  J Clin Pathol       Date:  1974-08       Impact factor: 3.411

View more
  32 in total

1.  Biophysical investigation of the ironome of human jurkat cells and mitochondria.

Authors:  Nema D Jhurry; Mrinmoy Chakrabarti; Sean P McCormick; Gregory P Holmes-Hampton; Paul A Lindahl
Journal:  Biochemistry       Date:  2012-06-22       Impact factor: 3.162

2.  Joint population pharmacokinetic analysis of zidovudine, lamivudine, and their active intracellular metabolites in HIV patients.

Authors:  C Bazzoli; H Bénech; E Rey; S Retout; D Salmon; X Duval; J M Tréluyer; F Mentré
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

3.  Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady State.

Authors:  Sharon M Seifert; Xinhui Chen; Amie L Meditz; Jose R Castillo-Mancilla; Edward M Gardner; Julie A Predhomme; Carolyn Clayton; Gregory Austin; Brent E Palmer; Jia-Hua Zheng; Brandon Klein; Becky J Kerr; L Anthony Guida; Caitlin Rower; Joseph E Rower; Jennifer J Kiser; Lane R Bushman; Samantha MaWhinney; Peter L Anderson
Journal:  AIDS Res Hum Retroviruses       Date:  2016-09-19       Impact factor: 2.205

4.  Pharmacokinetics of long-acting tenofovir alafenamide (GS-7340) subdermal implant for HIV prophylaxis.

Authors:  Manjula Gunawardana; Mariana Remedios-Chan; Christine S Miller; Rob Fanter; Flora Yang; Mark A Marzinke; Craig W Hendrix; Martin Beliveau; John A Moss; Thomas J Smith; Marc M Baum
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

5.  Spatial modulation spectroscopy for imaging and quantitative analysis of single dye-doped organic nanoparticles inside cells.

Authors:  Mary Sajini Devadas; Tuphan Devkota; Samit Guha; Scott K Shaw; Bradley D Smith; Gregory V Hartland
Journal:  Nanoscale       Date:  2015-06-07       Impact factor: 7.790

6.  Evidence and possible consequences of the phosphorylation of nucleoside reverse transcriptase inhibitors in human red blood cells.

Authors:  Lucie Durand-Gasselin; David Da Silva; Henri Benech; Alain Pruvost; Jacques Grassi
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

7.  Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue.

Authors:  William A Lee; Gong-Xin He; Eugene Eisenberg; Tomas Cihlar; Swami Swaminathan; Andrew Mulato; Kenneth C Cundy
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

Review 8.  Pharmacology of Antiretrovirals in the Female Genital Tract for HIV Prevention.

Authors:  Melanie R Nicol; Joseph A Corbino; Mackenzie L Cottrell
Journal:  J Clin Pharmacol       Date:  2018-06-14       Impact factor: 3.126

9.  Inhibition of HIV Expression and Integration in Macrophages by Methylglyoxal-Bis-Guanylhydrazone.

Authors:  Xia Jin; Michael S McGrath; Hua Xu
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

10.  Blood lymphocyte volumes and diameters in patients with chronic lymphocytic leukemia and normal controls.

Authors:  R Kuse; S Schuster; H Schübbe; S Dix; K Hausmann
Journal:  Blut       Date:  1985-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.